Charles E. Heckler

9.3k total citations · 2 hit papers
130 papers, 6.6k citations indexed

About

Charles E. Heckler is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Charles E. Heckler has authored 130 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 48 papers in Pulmonary and Respiratory Medicine and 21 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Charles E. Heckler's work include Cancer survivorship and care (53 papers), Cancer-related cognitive impairment studies (43 papers) and Childhood Cancer Survivors' Quality of Life (19 papers). Charles E. Heckler is often cited by papers focused on Cancer survivorship and care (53 papers), Cancer-related cognitive impairment studies (43 papers) and Childhood Cancer Survivors' Quality of Life (19 papers). Charles E. Heckler collaborates with scholars based in United States, France and Canada. Charles E. Heckler's co-authors include Gary R. Morrow, Karen M. Mustian, Michelle C. Janelsins, Oxana Palesh, Luke J. Peppone, Carl J. Huberty, Joseph A. Roscoe, Supriya G. Mohile, Lisa K. Sprod and Charles Kamen and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Technometrics.

In The Last Decade

Charles E. Heckler

124 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue

2017 570 citations Karen M. Mustian, Charles E. Heckler et al. profile →
Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study

2017 270 citations Michelle C. Janelsins, Charles E. Heckler et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles E. Heckler United States	42	2.6k	1.8k	1.1k	730	645	130	6.6k
Jia He China	64	2.3k 0.9×	1.5k 0.8×	412 0.4×	1.0k 1.4×	205 0.3×	493	17.4k
Andrew Gray New Zealand	50	1.6k 0.6×	554 0.3×	685 0.6×	1.3k 1.8×	502 0.8×	349	14.6k
Malcolm Macleod United Kingdom	62	1.4k 0.5×	1.3k 0.7×	588 0.5×	1.8k 2.5×	150 0.2×	232	18.4k
Jun J. Mao United States	53	3.1k 1.2×	992 0.5×	1.2k 1.1×	738 1.0×	597 0.9×	350	10.2k
Linda S. Hynan United States	60	1.4k 0.5×	965 0.5×	844 0.8×	1.5k 2.0×	266 0.4×	307	14.4k
Εvangelos Εvangelou Greece	54	1.3k 0.5×	1.1k 0.6×	647 0.6×	1.2k 1.6×	349 0.5×	160	11.5k
Sabine Rohrmann Switzerland	56	1.2k 0.5×	1.2k 0.7×	386 0.3×	1.4k 1.9×	536 0.8×	353	10.4k
Jane Green United Kingdom	46	2.5k 1.0×	858 0.5×	643 0.6×	2.1k 2.9×	530 0.8×	125	14.1k
Karl‐Heinz Jöckel Germany	61	1.0k 0.4×	1.7k 0.9×	378 0.3×	1.1k 1.5×	300 0.5×	437	14.1k
Loki Natarajan United States	59	3.5k 1.4×	1.5k 0.8×	1.5k 1.3×	3.2k 4.5×	1.2k 1.9×	247	11.2k

Countries citing papers authored by Charles E. Heckler

Since Specialization

Citations

This map shows the geographic impact of Charles E. Heckler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Heckler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Heckler more than expected).

Fields of papers citing papers by Charles E. Heckler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Heckler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Heckler. The network helps show where Charles E. Heckler may publish in the future.

Co-authorship network of co-authors of Charles E. Heckler

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Heckler. A scholar is included among the top collaborators of Charles E. Heckler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Heckler. Charles E. Heckler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peppone, Luke J., Amber S. Kleckner, Chunkit Fung, et al.. (2024). High‐dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT. Cancer. 130(14). 2538–2551. 6 indexed citations

Janelsins, Michelle C., Mostafa Mohamed, Luke J. Peppone, et al.. (2021). Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy. JNCI Journal of the National Cancer Institute. 114(1). 47–59. 22 indexed citations

Williams, AnnaLynn M., Charles E. Heckler, Debra L. Barton, et al.. (2021). Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis. Breast Cancer Research and Treatment. 187(1). 275–285. 39 indexed citations

Jim, Heather, Aasha I. Hoogland, Hyo S. Han, et al.. (2020). A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures. Contemporary Clinical Trials. 91. 105976–105976. 8 indexed citations

Peoples, Anita R., Sheila N. Garland, Wilfred R. Pigeon, et al.. (2019). Cognitive Behavioral Therapy for Insomnia Reduces Depression in Cancer Survivors. Journal of Clinical Sleep Medicine. 15(1). 129–137. 46 indexed citations

Mohile, Supriya G., Allison Magnuson, Chintan Pandya, et al.. (2018). Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer. Journal of the National Comprehensive Cancer Network. 16(3). 301–309. 54 indexed citations

Kamen, Charles, Sheila N. Garland, Charles E. Heckler, et al.. (2017). Social Support, Insomnia, and Adherence to Cognitive Behavioral Therapy for Insomnia After Cancer Treatment. Behavioral Sleep Medicine. 17(1). 70–80. 25 indexed citations

Asare, Matthew, Luke J. Peppone, Joseph A. Roscoe, et al.. (2016). Racial Differences in Information Needs During and After Cancer Treatment: a Nationwide, Longitudinal Survey by the University of Rochester Cancer Center National Cancer Institute Community Oncology Research Program. Journal of Cancer Education. 33(1). 95–101. 13 indexed citations

Dale, William, Karen M. Mustian, Ashwin Kotwal, et al.. (2016). Novel physical activity interventions for older patients with prostate cancer on hormone therapy: A pilot randomized study. Journal of Geriatric Oncology. 7(2). 71–80. 50 indexed citations

10.

Janelsins, Michelle C., Luke J. Peppone, Charles E. Heckler, et al.. (2015). YOCAS©® Yoga Reduces Self-reported Memory Difficulty in Cancer Survivors in a Nationwide Randomized Clinical Trial. Integrative Cancer Therapies. 15(3). 263–271. 59 indexed citations

11.

Kamen, Charles, Karen M. Mustian, Charles E. Heckler, et al.. (2015). The association between partner support and psychological distress among prostate cancer survivors in a nationwide study. Journal of Cancer Survivorship. 9(3). 492–499. 70 indexed citations

12.

Chandwani, Kavita D., Charles E. Heckler, Supriya G. Mohile, et al.. (2014). Hot flashes severity, complementary and alternative medicine use, and self-rated health in women with breast cancer. EXPLORE. 10(4). 241–247. 10 indexed citations

13.

Lavigne, Jill E., Charles E. Heckler, Jennifer Mathews, et al.. (2012). A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors. Breast Cancer Research and Treatment. 136(2). 479–486. 37 indexed citations

14.

Mohile, Supriya G., Charles E. Heckler, Fan Lin, et al.. (2011). Age-related differences in symptoms and their interference with quality of life in 903 cancer patients undergoing radiation therapy. Journal of Geriatric Oncology. 2(4). 225–232. 43 indexed citations

15.

Janelsins, Michelle C., Paul G. Davis, Laurie Wideman, et al.. (2011). Effects of Tai Chi Chuan on Insulin and Cytokine Levels in a Randomized Controlled Pilot Study on Breast Cancer Survivors. Clinical Breast Cancer. 11(3). 161–170. 106 indexed citations

16.

Roscoe, Joseph A., Gary R. Morrow, Ben Colagiuri, et al.. (2009). Insight in the prediction of chemotherapy-induced nausea. Supportive Care in Cancer. 18(7). 869–876. 71 indexed citations

17.

Roscoe, Joseph A., Peter Bushunow, Pascal Jean‐Pierre, et al.. (2009). Acupressure Bands Are Effective in Reducing Radiation Therapy-Related Nausea. Journal of Pain and Symptom Management. 38(3). 381–389. 26 indexed citations

18.

Janelsins, Michelle C., Joseph A. Roscoe, Michel J. Berg, et al.. (2009). IGF-1 Partially Restores Chemotherapy-Induced Reductions in Neural Cell Proliferation in Adult C57BL/6 Mice. Cancer Investigation. 28(5). 544–553. 67 indexed citations

19.

Rao, Poduri S.R.S. & Charles E. Heckler. (1998). Multivariate One-Way Random Effects Model. American Journal of Mathematical and Management Sciences. 18(1-2). 109–130. 2 indexed citations

20.

Heckler, Charles E., et al.. (1998). Contribution plots: a missing link in multivariate quality control. International Journal of Applied Mathematics and Computer Science. 8(4). 775–792. 290 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact